These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 16156883

  • 1. Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.
    Henderson M, Safa F, Easterbrook P, Hotopf M.
    HIV Med; 2005 Sep; 6(5):347-52. PubMed ID: 16156883
    [Abstract] [Full Text] [Related]

  • 2. Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era.
    Jong E, Oudhoff LA, Epskamp C, Wagener MN, van Duijn M, Fischer S, van Gorp EC.
    AIDS; 2010 Jun 19; 24(10):1387-405. PubMed ID: 20523204
    [Abstract] [Full Text] [Related]

  • 3. Physiological and psychological correlates of fatigue in HIV disease.
    Phillips KD, Sowell RL, Rojas M, Tavakoli A, Fulk LJ, Hand GA.
    Biol Res Nurs; 2004 Jul 19; 6(1):59-74. PubMed ID: 15186708
    [Abstract] [Full Text] [Related]

  • 4. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
    Braitstein P, Montessori V, Chan K, Montaner JS, Schechter MT, O'Shaughnessy MV, Hogg RS.
    AIDS Care; 2005 May 19; 17(4):505-15. PubMed ID: 16036236
    [Abstract] [Full Text] [Related]

  • 5. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study.
    Préau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B, VESPA Study Group.
    AIDS; 2007 Jan 19; 21 Suppl 1():S19-27. PubMed ID: 17159583
    [Abstract] [Full Text] [Related]

  • 6. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A, Burgess P, Judd F, Grech P, Komiti A, Hoy J, Lloyd JH, Gibbie T, Street A.
    HIV Med; 2006 May 19; 7(4):205-12. PubMed ID: 16630032
    [Abstract] [Full Text] [Related]

  • 7. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
    Morgello S, Estanislao L, Simpson D, Geraci A, DiRocco A, Gerits P, Ryan E, Yakoushina T, Khan S, Mahboob R, Naseer M, Dorfman D, Sharp V, Manhattan HIV Brain Bank.
    Arch Neurol; 2004 Apr 19; 61(4):546-51. PubMed ID: 15096404
    [Abstract] [Full Text] [Related]

  • 8. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.
    Clin Ther; 2007 Jul 19; 29(7):1448-55. PubMed ID: 17825696
    [Abstract] [Full Text] [Related]

  • 9. Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series.
    Jacobson MC, Dezube BJ, Aboulafia DM.
    Clin Infect Dis; 2004 Oct 15; 39(8):1214-22. PubMed ID: 15486847
    [Abstract] [Full Text] [Related]

  • 10. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC.
    Clin Infect Dis; 2006 Jan 15; 42(2):252-9. PubMed ID: 16355337
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D, Creagh T, Leitz G, Anemia Prevalence Study Group.
    Curr Med Res Opin; 2007 Feb 15; 23(2):343-55. PubMed ID: 17288689
    [Abstract] [Full Text] [Related]

  • 12. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.
    Infection; 2008 Jun 15; 36(3):231-6. PubMed ID: 18463787
    [Abstract] [Full Text] [Related]

  • 13. [Quality of life, psychological and social aspects in patients with advanced HIV disease].
    Martín Suárez I, Cano Monchul R, Pérez de Ayala P, Aguayo Canela M, Cuesta F, Rodríguez P, Pujol de la Llave E.
    An Med Interna; 2002 Aug 15; 19(8):396-404. PubMed ID: 12244786
    [Abstract] [Full Text] [Related]

  • 14. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
    Resino S, Larrú B, Maria Bellón J, Resino R, de José MI, Navarro M, Léon JA, Ramos JT, Mellado MJ, Muñoz-Fernández MA.
    BMC Infect Dis; 2006 Jul 11; 6():107. PubMed ID: 16834769
    [Abstract] [Full Text] [Related]

  • 15. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG.
    HIV Med; 2007 Jan 11; 8(1):46-54. PubMed ID: 17305932
    [Abstract] [Full Text] [Related]

  • 16. Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy.
    Risa KJ, Nepon L, Justis JC, Panwalker A, Berman SM, Cinti S, Wagener MM, Singh N.
    Int J STD AIDS; 2002 Oct 11; 13(10):706-13. PubMed ID: 12396542
    [Abstract] [Full Text] [Related]

  • 17. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.
    Clin Infect Dis; 2005 Dec 01; 41(11):1662-70. PubMed ID: 16267741
    [Abstract] [Full Text] [Related]

  • 18. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
    Vellozzi C, Brooks JT, Bush TJ, Conley LJ, Henry K, Carpenter CC, Overton ET, Hammer J, Wood K, Holmberg SD, SUN Study Investigators.
    Am J Epidemiol; 2009 Mar 01; 169(5):642-52. PubMed ID: 19074775
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
    Siddiqui U, Bini EJ, Chandarana K, Leong J, Ramsetty S, Schiliro D, Poles M.
    J Clin Gastroenterol; 2007 Mar 01; 41(5):484-90. PubMed ID: 17450031
    [Abstract] [Full Text] [Related]

  • 20. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.
    HIV Med; 2006 Mar 01; 7(2):99-104. PubMed ID: 16420254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.